Handbook of the Cerebellum and Cerebellar Disorders pp 2269-2311 | Cite as
Mitochondria, double-membrane organelles, are the major site of energy production and vital components of all eukaryotic cells because of the presence in their inner membrane of the respiratory chain (RC) which accomplishes oxidative phosphorylation (OXPHOS). In addition to respiration, mitochondria carry out diverse tasks which include import of proteins, ions, and metabolites, anaplerotic and degradative metabolic reactions, organelle dynamics, and signaling for apoptosis. Despite this multiplicity of functions, the term “mitochondrial disorders” is currently ascribed to OXPHOS diseases. Given the complexity of its biochemistry and of its peculiar dual genetic control, proper OXPHOS is a process that requires the assembly of numerous different proteins coded either by the mitochondrial genome or by the nuclear genome, and the orchestrated function of the five respiratory chain enzyme complexes packaged in the RC, the special hetero-multimeric structure of the inner mitochondrial membrane. Hence, mutations in mitochondrial DNA genes or in nuclear DNA genes encoding integral proteins of the RC subcomplexes, their regulatory and assembly factors, and the set of proteins that complete and regulate cellular bioenergetics, cause OXPHOS dysfunction and a corresponding variety of genetic diseases with heterogeneous clinical manifestations. This chapter focuses on mitochondrial disorders that express significant pathology in the cerebellum and in its long-tract connections with the peripheral organs, particularly the neuromuscular and osteoarticular systems, and manifest with spinocerebellar ataxia as the prominent symptom or sign.
KeywordsPurkinje Cell Spinocerebellar Ataxia Cerebellar Atrophy Friedreich Ataxia FRDA Patient
- Berkovic SF, Cochius J, Andermann E et al (1993) Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia 3:19–30Google Scholar
- Cohen BH, Chinnery PF, Copeland WC (2010) POLG-related disorders (Updated March 16, 2010). In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds). GeneReviews at GeneTests: Medical Genetics Information Resource (database online). University of Washington, Seattle. 1993–2011. http://www.genetests.org.
- Craig K, Ferrari G, Tiangyou W et al. (2007) The A467T and W748S POLG substitutions are a rare cause of adult-onset ataxia in Europe. Brain 130: E69; author reply E70Google Scholar
- Di Donato S, Taroni F (2008) Disorders of lipid metabolism. In: Rosemberg R, DiMauro S, Paulson et al. (eds) The molecular and genetic basis of neurological and psychiatric disease, 4th edn. Wolter Kluvers / Lippincot Williams & Wilkins, Philadelphia, pp 610–623Google Scholar
- Di Mauro S, Hirano M, Kaufmann P et al (2002) Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol 89:217–229Google Scholar
- Fukuhara N (1991) MERRF: a clinicopathological study – relationships between myoclonus epilepsies and mitochondrial myopathies. Rev Neurol (Paris) 147:476–79Google Scholar
- Gellera C, Pareyson D, Castellotti B et al (1997) Very late onset Friedreich’s ataxia without genetically confirmed Friedreich ataxia. Brain 131:1035–1045Google Scholar
- Huizing M (1998) Mitochondrial transmembrane carriers in mitochondriocytopathies. Work of Thesis, Kattholieke Universiteit Nijmegen, pp 8–34Google Scholar
- Kearney M, Orrell RW et al. (2009) Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev CD007791Google Scholar
- Naviaux RK, Nguyen KV et al (2004) POLG mutations associated with Alpers’ syndrome. Neurology 60:1206–1208Google Scholar
- Stryer L (1988) Biochemistry, 3rd edn. Freeman WH and company, New York, pp 373–379Google Scholar
- Tzoulis C, Bindoff LA (2009) The syndrome of mitochondrial spinocerebellar ataxias and epilepsy caused by POLG mutations. Adv Clin Neurosci Rehabil 9:13–16Google Scholar